4.6 Article

Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Design of a Randomized Clinical Trial of Perioperative Vaginal Estrogen Versus Placebo With Transvaginal Native Tissue Apical Prolapse Repair (Investigation to Minimize Prolapse Recurrence of the Vagina using Estrogen: IMPROVE)

David D. Rahn et al.

Summary: This study outlines the rationale and design for a clinical trial comparing conjugated estrogen vaginal cream with placebo in postmenopausal women with pelvic organ prolapse undergoing a native tissue apical repair. The main outcome is surgical success at 12 months based on objective and subjective criteria, with time-to-failure compared up to 36 months postoperatively. Secondary outcomes include quality-of-life metrics, sexual function, vaginal atrophy symptoms, and body image.

FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY (2021)

Article Health Care Sciences & Services

Identification of the Urogenital Distress Inventory-6 and the Incontinence Impact Questionnaire-7 cutoff scores in urinary incontinent women

Katarzyna Skorupska et al.

Summary: This study aimed to determine the cutoff scores for UDI-6 and IIQ-7 in women with urinary incontinence (UI). The results showed that the optimal cutoff values for distinguishing between symptomatic and asymptomatic women were 33.33 for UDI-6 and 9.52 for IIQ-7, based on the ROC curve analysis with high AUC values of 0.94 for UDI-6 and 0.91 for IIQ-7.

HEALTH AND QUALITY OF LIFE OUTCOMES (2021)

Article Geriatrics & Gerontology

Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning

JoAnn V. Pinkerton et al.

MATURITAS (2017)

Article Obstetrics & Gynecology

Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment

David Rich Ellington et al.

FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY (2016)

Review Obstetrics & Gynecology

Assessment of vaginal atrophy: a review

M. A. Weber et al.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2015)

Review Obstetrics & Gynecology

Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines

David D. Rahn et al.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2015)

Review Multidisciplinary Sciences

Local Oestrogen for Pelvic Floor Disorders: A Systematic Review

M. A. Weber et al.

PLOS ONE (2015)

Article Endocrinology & Metabolism

Effects of Preoperative Local Estrogen in Postmenopausal Women With Prolapse: A Randomized Trial

David D. Rahn et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Review Obstetrics & Gynecology

Vaginal Estrogen for Genitourinary Syndrome of Menopause A Systematic Review

David D. Rahn et al.

OBSTETRICS AND GYNECOLOGY (2014)

Article Obstetrics & Gynecology

Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder

Rebecca S. Nelken et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)

Article Obstetrics & Gynecology

Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally

Gloria Bachmann et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)

Article Obstetrics & Gynecology

Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)

MD Barber et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)

Article Obstetrics & Gynecology

The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: A comparative study

J Manonai et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2001)